Merrimack Pharmaceuticals Inc (MACK)
14.72
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
14.73
0.00 (0.00%)
After-Hours: 19:46
Merrimack Pharmaceuticals Enterprise Value: 195.11M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 195.11M |
| April 22, 2024 | 195.18M |
| April 19, 2024 | 195.03M |
| April 18, 2024 | 194.45M |
| April 17, 2024 | 194.45M |
| April 16, 2024 | 194.45M |
| April 15, 2024 | 194.45M |
| April 12, 2024 | 194.45M |
| April 11, 2024 | 195.18M |
| April 10, 2024 | 195.03M |
| April 09, 2024 | 195.18M |
| April 08, 2024 | 194.74M |
| April 05, 2024 | 194.89M |
| April 04, 2024 | 194.74M |
| April 03, 2024 | 194.89M |
| April 02, 2024 | 195.18M |
| April 01, 2024 | 195.32M |
| March 28, 2024 | 195.76M |
| March 27, 2024 | 195.47M |
| March 26, 2024 | 195.03M |
| March 25, 2024 | 195.18M |
| March 22, 2024 | 196.05M |
| March 21, 2024 | 194.60M |
| March 20, 2024 | 194.60M |
| March 19, 2024 | 194.60M |
| Date | Value |
|---|---|
| March 18, 2024 | 195.03M |
| March 15, 2024 | 195.32M |
| March 14, 2024 | 193.93M |
| March 13, 2024 | 194.37M |
| March 12, 2024 | 193.79M |
| March 11, 2024 | 193.93M |
| March 08, 2024 | 194.80M |
| March 07, 2024 | 195.53M |
| March 06, 2024 | 194.66M |
| March 05, 2024 | 194.37M |
| March 04, 2024 | 191.94M |
| March 01, 2024 | 192.66M |
| February 29, 2024 | 192.08M |
| February 28, 2024 | 192.08M |
| February 27, 2024 | 192.23M |
| February 26, 2024 | 192.08M |
| February 23, 2024 | 192.52M |
| February 22, 2024 | 192.37M |
| February 21, 2024 | 191.80M |
| February 20, 2024 | 192.08M |
| February 16, 2024 | 192.08M |
| February 15, 2024 | 192.08M |
| February 14, 2024 | 191.65M |
| February 13, 2024 | 196.39M |
| February 12, 2024 | 181.90M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.230M
Minimum
Mar 20 2020
196.39M
Maximum
Feb 13 2024
80.33M
Average
56.11M
Median
May 13 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.275M |
| Palatin Technologies Inc | 18.75M |
| iBio Inc | 16.49M |
| Theriva Biologics Inc | -13.75M |
| Oragenics Inc | 3.306M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.24M |
| Total Expenses (Quarterly) | 0.49M |
| EPS Diluted (Quarterly) | -0.01 |
| Earnings Yield | -0.54% |
| Normalized Earnings Yield | -89.64 |